Cure Childhood Cancer

Understanding the Research

We often get questions about where CURE Childhood Cancer has invested its research funding and what that research is teaching us. To help you understand the state of childhood cancer, the status of research projects and what we’re funding, we put together 9067-0702this series of documents. Click on any title to download the PDF.

 

CURE Investment Fact Sheet
Read about some of our recent research investments at the Aflac Cancer Center, one of the premier pediatric cancer research centers in the United States.

Research Summary: Cure 2013-2014 Research Initiatives

This past year, CURE Childhood Cancer’s Board of Directors voted to fund nearly $2.5 million in pediatric cancer research initiatives, the largest grant amount in the organization’s history! The grants support 16 research projects aimed at developing new, more effective and less toxic therapies for pediatric cancer patients, three human drug therapy trials, two pediatric research fellows and pre-trial testing.

Article: A Year of Progress

by Laura Scholz

Learn more about the genetic causes of cancer and resistance to treatment, as well as CURE’s active role in cancer support and research.

Article: CURE Funds Critical Pediatric Bone Cancer Research

by Laura Scholz

CURE awarded Dr. Eugenie S. Kleinerman of the University of Texas Anderson Children’s Cancer Hospital a $100,000 grant to aid in the development of new therapies to fight osteosarcoma. Dr. Kleinerman shares her groundbreaking research project to give patients the safest treatment possible for this deadly, rare disease and improve the quality of life for post-cancer patients.

Article: Dr. Howard Katzenstein’s Mission to Cure Pediatric Cancers

by Laura Scholz

CURE’s Childhood Cancer Research Initiatives equaled more than $1.7 million in 2012-2013, and the grants specifically targeted the most challenging pediatric cancers to cure. Two of CURE’s research funds went to Dr. Howard Katzenstein of the Aflac Cancer and Blood Disorders Center at Children’s Healthcare of Atlanta, who shares his research and mission to do more than treat pediatric cancer patients but to find a CURE.

Article: Devastating Pediatric Malignant Brain Tumor Could Be Disabled At the Cellular Level

by Dr. Anna Kenney

Dr. Anna Kenney, Director of the Pediatric Neuro-oncology Basic Research Program at the Aflac Cancer Center of Children’s Healthcare of Atlanta, discusses an alternative and more precise way to treat the most common malignant brain tumors in children, preventing long-term side effects of harsher, traditional treatments.

Article: CURE-Funded Research Seeks to Understand and Treat Drug-resistant Tumors

Learn more about CURE’s research efforts with Emory University and Children’s Healthcare of Atlanta to understand tumor growth at the molecular level when determining new ways to treat drug-resistant tumors.

  • Screen Shot 2014-09-19 at 2.48.10 PM

    YOUR DONATION MAKES A DIFFERENCE

    When you make a donation to CURE Childhood Cancer, you are directly supporting CURE's annual $2.5 million commitment to fund life-saving pediatric research as well as helping us meet the critical and urgent needs of patients and families in the midst of their battle.

  • Screen Shot 2014-08-07 at 11.46.04 AM

    10th ANNUAL "A TRIBUTE TO OUR QUIET HEROES"

    Tickets are on sale now for the 10th Annual luncheon celebrating the mothers of children diagnosed with cancer. Join us Saturday, September 27th at the InterContinental Buckhead. Click here to purchase luncheon tickets, click here to purchase raffle tickets, or click here to bid in the online auction.